Back

SGLT2 inhibitors in heart failure: insights from plasma proteomics

European Heart Journal

7 November 2022
Organised by: Logo
Read full article
ESC Journals HEART FAILURE Chronic Heart Failure

Contributors

Clemens Gutmann
Clemens Gutmann

Author

Medical University of Vienna Vienna , Austria

Thomas A Zelniker
Thomas A Zelniker

Author

Medical University of Vienna Vienna , Austria

Manuel Mayr
Manuel Mayr

Author

National Heart and Lung Institute Imperial College London , United Kingdom of Great Britain & Northern Ireland

You may be interested in
thumbnail
Congress Session
Biomarkers in the era of 'OMICS': potential beyond diagnosis
19 May 2025
thumbnail
Congress Presentation
Predictors of worsening kidney function and their relation to SGLT2 inhibitor dapagliflozin administration in type 2 diabetes mellitus patients with chronic heart failure
25 April 2024
thumbnail
Congress Session
The power of now: a focus on SGLT2 inhibitors for heart failure in the hospital
17 May 2025
thumbnail
Congress Presentation
Mechanisms of the clinical benefits of SGLT2i in heart failure (EMPEROR-Pooled)
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources